[Pharmacological studies on yohimbic acid ethyl ester (A 38) and 4-=2-(p-butoxyphenyl)-1,3-dioxolan-2-ylmethyl=-morpholine methobromide (Q 160) as well as the influence of these substances on reserpine action].
D000959:Antihypertensive Agents; D009025:Morpholines; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000494:pharmacology*; D013565:Sympatholytics; D014665:Vasodilator Agents; D015016:Yohimbine / Q000031:analogs & derivatives
D000959:Antihypertensive Agents; D009025:Morpholines; D046948:Secologanin Tryptamine Alkaloids; D013565:Sympatholytics; D014665:Vasodilator Agents; D015016:Yohimbine; D012110:Reserpine; C037574:morpholine
RAUWOLFIA ALKALOIDS/effects; SYMPATHOLYTICS/effects; YOHIMBINE/derivatives
Pharmakologische Untersuchung über Yohimboasäureäthylester (A 38) und 2-(p-Butoxyphenyl)-2-(tetrahydro-1, 4-oxazinomethyl)-dioxolan-(1, 3)-methobromid (Q 160) sowie den Einfluss dieser Substanzen auf die Reserpin-Wirkung.